PureTech Health plc – Half-Year Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Bristol-Myers Squibb Co. (BMY) PT Raised to $51 at Jefferies
August 28, 2024 5:41 AM EDTJefferies analyst Akash Tewari raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $51.00 (from $49.00) while maintaining a Hold rating.
The analyst comments "Bayer will present asundexian OCEANIC-AF data at ESC (stopped due to inferior efficacy vs Eliquis). While we remain on... More



